Libre dramatically reduced dangerous ketoacidosis in France!
I know that this text and the study will be associated with advertising Abbott, and the fact that almost all the authors of the study I will write about – are in some way connected with Abbott speaks in favor of that. However, I think that the relevant figures and the way the study was done deserve attention. In addition, I think that this study benefits other sensor manufacturers, one of which has already come to Croatia (Medtrum), and we expect more soon.
Diabetic ketoacidosis is a life-threatening condition of persistent hyperglycemia that can be avoided by education and frequent measurement of sugar levels. Ketoacidosis, in addition to being life-threatening, is also dangerous for the costs of the Croatian Health Insurance Fund due to the costs of hospitalization, sick leave etc.
What did the study presented at the ADA Chicago show?
French researchers analyzed data from 33,203 people with type 1 diabetes and 40,955 people with type 2 diabetes – they compared the number of ketoacidoses before they were entitled to Libre and one year after using Libre.
The annual number of dangerous ketoacidosis is reduced by 52% in type 1 and 47% in people with type 2 diabetes!
In addition, these savings are found in both well-regulated people with diabetes, and those who are quite uninterested in their disease. In particular, Libre has not only helped those who used to measure blood sugar a lot, but also those who weren’t really interested in it!
Motivating a person with poorly controlled diabetes to better self-control is a success
And that, in turn, is another significant long-term savings for the health care system, this time at the huge cost of costly complications such as blindness, amputations, and dialysis.
The above graph resulting from an analysis of the national French database shows that for every 100 patients with a T1D diagnosis, an average of 5.5 of them fell into ketoacidosis before Libre in a year. After Libre, the number of these same T1Ds dropped to 2.59 patients per 100 patients. For people with type 2 diabetes, the numbers are slightly lower, but they are still halved – from 1.7 ketoacidoses per 100 inhabitants per year, they have dropped to only 0.9.
I have already written before about a girl who was seriously injured in a car crash and rushed to hospital Vuk Vrhovac. She fell into ketoacidosis and spent almost a week in the hospital recovering. In addition to suffering severe injuries, the cost of her recovery to the health care system was also solid. Therefore, if there is a technology that doubles the chances of ketoacidosis occurring – then it needs to be secured. Thanks to HZZO (Croatian National Health Insurance Fund) for doing this for all people with type 1 diabetes who need it.